Compile Data Set for Download or QSAR

Found 1090 hits with Last Name = 'zahn' and Initial = 'sk'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117856 (US8653087, III-536) Show SMILES COCCN1CCN(CC1)c1ncc2ncnc(Nc3cc(ccc3C)C(=O)Nc3ccc(F)c(c3)C(F)(F)F)c2n1 Show InChI InChI=1S/C28H28F4N8O2/c1-17-3-4-18(26(41)36-19-5-6-21(29)20(14-19)28(30,31)32)13-22(17)37-25-24-23(34-16-35-25)15-33-27(38-24)40-9-7-39(8-10-40)11-12-42-2/h3-6,13-16H,7-12H2,1-2H3,(H,36,41)(H,34,35,37)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117871 (US8653087, III-551) Show SMILES COc1ccc(NC(=O)c2ccc(C)c(Nc3ncnc4cnc(nc34)N3CCCOCC3)c2)cc1C(F)(F)F Show InChI InChI=1S/C27H26F3N7O3/c1-16-4-5-17(25(38)34-18-6-7-22(39-2)19(13-18)27(28,29)30)12-20(16)35-24-23-21(32-15-33-24)14-31-26(36-23)37-8-3-10-40-11-9-37/h4-7,12-15H,3,8-11H2,1-2H3,(H,34,38)(H,32,33,35)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117913 (US8653087, III-593) Show SMILES COc1ccc(NC(=O)c2ccc(C)c(Nc3ncnc4cnc(NC5CC(C5)N5CCN(C)CC5)nc34)c2)cc1C(F)(F)F |(-12.95,2.15,;-12.95,.61,;-11.61,-.16,;-11.61,-1.7,;-10.28,-2.47,;-8.94,-1.7,;-7.61,-2.47,;-6.28,-1.7,;-6.28,-.16,;-4.94,-2.47,;-4.94,-4.01,;-3.61,-4.78,;-2.28,-4.01,;-.94,-4.78,;-2.28,-2.47,;-.94,-1.7,;-.94,-.16,;-2.28,.61,;-2.28,2.15,;-.94,2.92,;.39,2.15,;1.72,2.92,;3.06,2.15,;3.06,.61,;4.39,-.16,;5.73,.61,;7.21,.21,;7.61,1.7,;6.12,2.1,;8.94,2.47,;10.28,1.7,;11.61,2.47,;11.61,4.01,;12.95,4.78,;10.28,4.78,;8.94,4.01,;1.72,-.16,;.39,.61,;-3.61,-1.7,;-8.94,-.16,;-10.28,.61,;-10.28,2.15,;-11.61,2.92,;-8.94,2.92,;-8.94,1.38,)| Show InChI InChI=1S/C31H34F3N9O2/c1-18-4-5-19(29(44)38-20-6-7-26(45-3)23(15-20)31(32,33)34)12-24(18)40-28-27-25(36-17-37-28)16-35-30(41-27)39-21-13-22(14-21)43-10-8-42(2)9-11-43/h4-7,12,15-17,21-22H,8-11,13-14H2,1-3H3,(H,38,44)(H,35,39,41)(H,36,37,40)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117918 (US8653087, III-598) Show SMILES CN(C)CCCNc1ncc2ncnc(Nc3cc(ccc3C)C(=O)Nc3cc(on3)C(C)(C)C)c2n1 Show InChI InChI=1S/C26H33N9O2/c1-16-8-9-17(24(36)32-21-13-20(37-34-21)26(2,3)4)12-18(16)31-23-22-19(29-15-30-23)14-28-25(33-22)27-10-7-11-35(5)6/h8-9,12-15H,7,10-11H2,1-6H3,(H,27,28,33)(H,29,30,31)(H,32,34,36)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117923 (US8653087, III-603) Show SMILES CN1CCC2(CCN(C2)c2ncc3ncnc(Nc4cc(ccc4C)C(=O)Nc4cc(on4)C(C)(C)C)c3n2)C1 Show InChI InChI=1S/C29H35N9O2/c1-18-6-7-19(26(39)34-23-13-22(40-36-23)28(2,3)4)12-20(18)33-25-24-21(31-17-32-25)14-30-27(35-24)38-11-9-29(16-38)8-10-37(5)15-29/h6-7,12-14,17H,8-11,15-16H2,1-5H3,(H,31,32,33)(H,34,36,39)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117930 (US8653087, IV-2) Show SMILES Cc1ccc(NC(=O)c2cccc(c2)C(C)(C)C#N)cc1Nc1ncnc2cnc(nc12)N1CCOCC1 Show InChI InChI=1S/C28H28N8O2/c1-18-7-8-21(33-26(37)19-5-4-6-20(13-19)28(2,3)16-29)14-22(18)34-25-24-23(31-17-32-25)15-30-27(35-24)36-9-11-38-12-10-36/h4-8,13-15,17H,9-12H2,1-3H3,(H,33,37)(H,31,32,34)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117956 (US8653087, IV-28) Show SMILES CN1CCC(CC1)Nc1ncc2ncnc(Nc3cc(NC(=O)c4cccc(c4)C(C)(C)C#N)ccc3C)c2n1 Show InChI InChI=1S/C30H33N9O/c1-19-8-9-23(35-28(40)20-6-5-7-21(14-20)30(2,3)17-31)15-24(19)37-27-26-25(33-18-34-27)16-32-29(38-26)36-22-10-12-39(4)13-11-22/h5-9,14-16,18,22H,10-13H2,1-4H3,(H,35,40)(H,32,36,38)(H,33,34,37)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM118008 (US8653087, VIII-1) Show SMILES CNc1ncnc2c(Nc3cc(NC(=O)c4cccc(c4)C(C)(C)C#N)ccc3C)ncnc12 Show InChI InChI=1S/C25H24N8O/c1-15-8-9-18(32-24(34)16-6-5-7-17(10-16)25(2,3)12-26)11-19(15)33-23-21-20(28-14-31-23)22(27-4)30-13-29-21/h5-11,13-14H,1-4H3,(H,32,34)(H,27,29,30)(H,28,31,33)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117269 (US8653087, I-56) Show SMILES CN1CCC(CC1)N1CCN(CC1)c1nc(N)c2ncnc(Nc3cc(ccc3C)C(=O)Nc3cccc(c3)C(F)(F)F)c2n1 Show InChI InChI=1S/C31H35F3N10O/c1-19-6-7-20(29(45)38-22-5-3-4-21(17-22)31(32,33)34)16-24(19)39-28-26-25(36-18-37-28)27(35)41-30(40-26)44-14-12-43(13-15-44)23-8-10-42(2)11-9-23/h3-7,16-18,23H,8-15H2,1-2H3,(H,38,45)(H2,35,40,41)(H,36,37,39)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117271 (US8653087, I-58) Show SMILES Cc1ccc(cc1Nc1ncnc2c(N)nc(nc12)N1CCCN(CC1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F Show InChI InChI=1S/C29H30F3N9O/c1-17-6-7-18(27(42)36-20-5-2-4-19(15-20)29(30,31)32)14-22(17)37-26-24-23(34-16-35-26)25(33)39-28(38-24)41-11-3-10-40(12-13-41)21-8-9-21/h2,4-7,14-16,21H,3,8-13H2,1H3,(H,36,42)(H2,33,38,39)(H,34,35,37)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117273 (US8653087, I-60) Show SMILES Cc1ccc(cc1Nc1ncnc2c(N)nc(nc12)N1CCCN(CC1)c1ccncc1)C(=O)Nc1cccc(c1)C(F)(F)F Show InChI InChI=1S/C31H29F3N10O/c1-19-6-7-20(29(45)39-22-5-2-4-21(17-22)31(32,33)34)16-24(19)40-28-26-25(37-18-38-28)27(35)42-30(41-26)44-13-3-12-43(14-15-44)23-8-10-36-11-9-23/h2,4-11,16-18H,3,12-15H2,1H3,(H,39,45)(H2,35,41,42)(H,37,38,40)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117276 (US8653087, I-63) Show SMILES Cc1ccc(cc1Nc1ncnc2c(N)nc(nc12)N1CCCN(CC1)c1ncccn1)C(=O)Nc1cccc(c1)C(F)(F)F Show InChI InChI=1S/C30H28F3N11O/c1-18-7-8-19(27(45)39-21-6-2-5-20(16-21)30(31,32)33)15-22(18)40-26-24-23(37-17-38-26)25(34)42-29(41-24)44-12-4-11-43(13-14-44)28-35-9-3-10-36-28/h2-3,5-10,15-17H,4,11-14H2,1H3,(H,39,45)(H2,34,41,42)(H,37,38,40)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117351 (US8653087, III-31) Show SMILES COc1ccc(NC(=O)c2ccc(F)c(Nc3ncnc4cnc(nc34)N(C)CCN(C)C)c2)cc1C(F)(F)F Show InChI InChI=1S/C26H26F4N8O2/c1-37(2)9-10-38(3)25-31-13-20-22(36-25)23(33-14-32-20)35-19-11-15(5-7-18(19)27)24(39)34-16-6-8-21(40-4)17(12-16)26(28,29)30/h5-8,11-14H,9-10H2,1-4H3,(H,34,39)(H,32,33,35)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117361 (US8653087, III-41) Show SMILES COc1ccc(NC(=O)c2ccc(F)c(Nc3ncnc4cnc(nc34)N(C)C)c2)cc1C(F)(F)F Show InChI InChI=1S/C23H19F4N7O2/c1-34(2)22-28-10-17-19(33-22)20(30-11-29-17)32-16-8-12(4-6-15(16)24)21(35)31-13-5-7-18(36-3)14(9-13)23(25,26)27/h4-11H,1-3H3,(H,31,35)(H,29,30,32)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117427 (US8653087, III-107) Show SMILES Cc1ccc(cc1Nc1ncnc2cnc(NCc3cccnc3)nc12)C(=O)Nc1cc(CN2CCCC2)cc(c1)C(F)(F)F Show InChI InChI=1S/C32H30F3N9O/c1-20-6-7-23(30(45)41-25-12-22(18-44-9-2-3-10-44)11-24(14-25)32(33,34)35)13-26(20)42-29-28-27(39-19-40-29)17-38-31(43-28)37-16-21-5-4-8-36-15-21/h4-8,11-15,17,19H,2-3,9-10,16,18H2,1H3,(H,41,45)(H,37,38,43)(H,39,40,42)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117464 (US8653087, III-144) Show SMILES CN(C)CCOc1cc(NC(=O)c2ccc(C)c(Nc3ncnc4cnc(NCCF)nc34)c2)cc(c1)C(F)(F)F Show InChI InChI=1S/C27H28F4N8O2/c1-16-4-5-17(10-21(16)37-24-23-22(34-15-35-24)14-33-26(38-23)32-7-6-28)25(40)36-19-11-18(27(29,30)31)12-20(13-19)41-9-8-39(2)3/h4-5,10-15H,6-9H2,1-3H3,(H,36,40)(H,32,33,38)(H,34,35,37)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117466 (US8653087, III-146) Show SMILES CN(C)CCOc1cc(NC(=O)c2ccc(C)c(Nc3ncnc4cnc(NCC5CCOC5)nc34)c2)cc(c1)C(F)(F)F Show InChI InChI=1S/C30H33F3N8O3/c1-18-4-5-20(28(42)38-22-11-21(30(31,32)33)12-23(13-22)44-9-7-41(2)3)10-24(18)39-27-26-25(36-17-37-27)15-35-29(40-26)34-14-19-6-8-43-16-19/h4-5,10-13,15,17,19H,6-9,14,16H2,1-3H3,(H,38,42)(H,34,35,40)(H,36,37,39)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117469 (US8653087, III-149) Show SMILES CN(C)CCOc1cc(NC(=O)c2ccc(C)c(Nc3ncnc4cnc(nc34)N3CCOCC3)c2)cc(c1)C(F)(F)F Show InChI InChI=1S/C29H31F3N8O3/c1-18-4-5-19(27(41)36-21-13-20(29(30,31)32)14-22(15-21)43-11-6-39(2)3)12-23(18)37-26-25-24(34-17-35-26)16-33-28(38-25)40-7-9-42-10-8-40/h4-5,12-17H,6-11H2,1-3H3,(H,36,41)(H,34,35,37)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117471 (US8653087, III-151) Show SMILES COCCNc1ncc2ncnc(Nc3cc(ccc3C)C(=O)Nc3cc(OCCN(C)C)cc(c3)C(F)(F)F)c2n1 Show InChI InChI=1S/C28H31F3N8O3/c1-17-5-6-18(26(40)36-20-12-19(28(29,30)31)13-21(14-20)42-10-8-39(2)3)11-22(17)37-25-24-23(34-16-35-25)15-33-27(38-24)32-7-9-41-4/h5-6,11-16H,7-10H2,1-4H3,(H,36,40)(H,32,33,38)(H,34,35,37)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117476 (US8653087, III-156) Show SMILES CNc1ncc2ncnc(Nc3cc(ccc3C)C(=O)Nc3cc(OCCN(C)C)cc(c3)C(F)(F)F)c2n1 Show InChI InChI=1S/C26H27F3N8O2/c1-15-5-6-16(9-20(15)35-23-22-21(32-14-33-23)13-31-25(30-2)36-22)24(38)34-18-10-17(26(27,28)29)11-19(12-18)39-8-7-37(3)4/h5-6,9-14H,7-8H2,1-4H3,(H,34,38)(H,30,31,36)(H,32,33,35)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117489 (US8653087, III-169) Show SMILES COCCNc1ncc2ncnc(Nc3cc(ccc3C)C(=O)Nc3cc(cc(c3)C(F)(F)F)N(C)CCN(C)C)c2n1 Show InChI InChI=1S/C29H34F3N9O2/c1-18-6-7-19(12-23(18)38-26-25-24(35-17-36-26)16-34-28(39-25)33-8-11-43-5)27(42)37-21-13-20(29(30,31)32)14-22(15-21)41(4)10-9-40(2)3/h6-7,12-17H,8-11H2,1-5H3,(H,37,42)(H,33,34,39)(H,35,36,38)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117395 (US8653087, III-75) Show SMILES CC(C)(C)c1cc(NC(=O)c2ccc(Cl)c(Nc3ncnc4cnc(nc34)N3CCOCC3)c2)no1 Show InChI InChI=1S/C24H25ClN8O3/c1-24(2,3)18-11-19(32-36-18)30-22(34)14-4-5-15(25)16(10-14)29-21-20-17(27-13-28-21)12-26-23(31-20)33-6-8-35-9-7-33/h4-5,10-13H,6-9H2,1-3H3,(H,27,28,29)(H,30,32,34)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117563 (US8653087, III-243) Show SMILES CN(C)c1cccc(NC(=O)c2ccc(C)c(Nc3ncnc4cnc(nc34)N3CC[C@@H](F)C3)c2)c1 |r| Show InChI InChI=1S/C26H27FN8O/c1-16-7-8-17(25(36)31-19-5-4-6-20(12-19)34(2)3)11-21(16)32-24-23-22(29-15-30-24)13-28-26(33-23)35-10-9-18(27)14-35/h4-8,11-13,15,18H,9-10,14H2,1-3H3,(H,31,36)(H,29,30,32)/t18-/m1/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117607 (US8653087, III-287) Show SMILES Cc1ccc(cc1Nc1ncnc2cnc(nc12)N1CC[C@H](F)C1)C(=O)Nc1cccc(c1)C(F)(F)F |r| Show InChI InChI=1S/C25H21F4N7O/c1-14-5-6-15(23(37)33-18-4-2-3-16(10-18)25(27,28)29)9-19(14)34-22-21-20(31-13-32-22)11-30-24(35-21)36-8-7-17(26)12-36/h2-6,9-11,13,17H,7-8,12H2,1H3,(H,33,37)(H,31,32,34)/t17-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117610 (US8653087, III-290) Show SMILES Cc1ccc(cc1Nc1ncnc2cnc(nc12)N1CC[C@H](F)C1)C(=O)Nc1cccc(OC(F)(F)F)c1 |r| Show InChI InChI=1S/C25H21F4N7O2/c1-14-5-6-15(23(37)33-17-3-2-4-18(10-17)38-25(27,28)29)9-19(14)34-22-21-20(31-13-32-22)11-30-24(35-21)36-8-7-16(26)12-36/h2-6,9-11,13,16H,7-8,12H2,1H3,(H,33,37)(H,31,32,34)/t16-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117617 (US8653087, III-297) Show SMILES CN1CCN(CC1)c1ncc2ncnc(Nc3cc(ccc3C)C(=O)Nc3ccc(F)c(c3)C(F)(F)F)c2n1 Show InChI InChI=1S/C26H24F4N8O/c1-15-3-4-16(24(39)34-17-5-6-19(27)18(12-17)26(28,29)30)11-20(15)35-23-22-21(32-14-33-23)13-31-25(36-22)38-9-7-37(2)8-10-38/h3-6,11-14H,7-10H2,1-2H3,(H,34,39)(H,32,33,35)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117669 (US8653087, III-349) Show SMILES Cc1ccc(cc1Nc1ncnc2cnc(NC3CCOC3)nc12)C(=O)Nc1cccc(c1)C(F)(F)F Show InChI InChI=1S/C25H22F3N7O2/c1-14-5-6-15(23(36)32-17-4-2-3-16(10-17)25(26,27)28)9-19(14)34-22-21-20(30-13-31-22)11-29-24(35-21)33-18-7-8-37-12-18/h2-6,9-11,13,18H,7-8,12H2,1H3,(H,32,36)(H,29,33,35)(H,30,31,34)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117671 (US8653087, III-351) Show SMILES CCN1CCN(CC1)c1cc(NC(=O)c2ccc(C)c(Nc3ncnc4cnc(NC5CCOC5)nc34)c2)cc(c1)C(F)(F)F Show InChI InChI=1S/C31H34F3N9O2/c1-3-42-7-9-43(10-8-42)24-14-21(31(32,33)34)13-23(15-24)38-29(44)20-5-4-19(2)25(12-20)40-28-27-26(36-18-37-28)16-35-30(41-27)39-22-6-11-45-17-22/h4-5,12-16,18,22H,3,6-11,17H2,1-2H3,(H,38,44)(H,35,39,41)(H,36,37,40)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117675 (US8653087, III-355) Show SMILES Cc1ccc(cc1Nc1ncnc2cnc(NC3CCOC3)nc12)C(=O)Nc1cc(ccn1)C(F)(F)F Show InChI InChI=1S/C24H21F3N8O2/c1-13-2-3-14(22(36)34-19-9-15(4-6-28-19)24(25,26)27)8-17(13)33-21-20-18(30-12-31-21)10-29-23(35-20)32-16-5-7-37-11-16/h2-4,6,8-10,12,16H,5,7,11H2,1H3,(H,28,34,36)(H,29,32,35)(H,30,31,33)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117677 (US8653087, III-357 | US8653087, III-364) Show SMILES Cc1ccc(cc1Nc1ncnc2cnc(NC3CCOC3)nc12)C(=O)Nc1cc(on1)C(C)(C)C Show InChI InChI=1S/C25H28N8O3/c1-14-5-6-15(23(34)31-20-10-19(36-33-20)25(2,3)4)9-17(14)30-22-21-18(27-13-28-22)11-26-24(32-21)29-16-7-8-35-12-16/h5-6,9-11,13,16H,7-8,12H2,1-4H3,(H,26,29,32)(H,27,28,30)(H,31,33,34)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117677 (US8653087, III-357 | US8653087, III-364) Show SMILES Cc1ccc(cc1Nc1ncnc2cnc(NC3CCOC3)nc12)C(=O)Nc1cc(on1)C(C)(C)C Show InChI InChI=1S/C25H28N8O3/c1-14-5-6-15(23(34)31-20-10-19(36-33-20)25(2,3)4)9-17(14)30-22-21-18(27-13-28-22)11-26-24(32-21)29-16-7-8-35-12-16/h5-6,9-11,13,16H,7-8,12H2,1-4H3,(H,26,29,32)(H,27,28,30)(H,31,33,34)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117708 (US8653087, III-388) Show SMILES CN1CCN(CC1)c1cc(NC(=O)c2ccc(F)c(Nc3ncnc4cnc(NC5CCOC5)nc34)c2)cc(c1)C(F)(F)F Show InChI InChI=1S/C29H29F4N9O2/c1-41-5-7-42(8-6-41)21-12-18(29(31,32)33)11-20(13-21)37-27(43)17-2-3-22(30)23(10-17)39-26-25-24(35-16-36-26)14-34-28(40-25)38-19-4-9-44-15-19/h2-3,10-14,16,19H,4-9,15H2,1H3,(H,37,43)(H,34,38,40)(H,35,36,39)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117710 (US8653087, III-390) Show SMILES COc1ccc(NC(=O)c2ccc(F)c(Nc3ncnc4cnc(NC5CCOC5)nc34)c2)cc1C(F)(F)F Show InChI InChI=1S/C25H21F4N7O3/c1-38-20-5-3-14(9-16(20)25(27,28)29)33-23(37)13-2-4-17(26)18(8-13)35-22-21-19(31-12-32-22)10-30-24(36-21)34-15-6-7-39-11-15/h2-5,8-10,12,15H,6-7,11H2,1H3,(H,33,37)(H,30,34,36)(H,31,32,35)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117713 (US8653087, III-393) Show SMILES Fc1ccc(cc1Nc1ncnc2cnc(nc12)N1CCOCC1)C(=O)Nc1cc(ccn1)C(F)(F)F Show InChI InChI=1S/C23H18F4N8O2/c24-15-2-1-13(21(36)33-18-10-14(3-4-28-18)23(25,26)27)9-16(15)32-20-19-17(30-12-31-20)11-29-22(34-19)35-5-7-37-8-6-35/h1-4,9-12H,5-8H2,(H,28,33,36)(H,30,31,32)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117730 (US8653087, III-410) Show SMILES Cc1ccc(cc1Nc1ncnc2cnc(nc12)N1CCOCC1)C(=O)Nc1cccc(OC(F)(F)F)c1 Show InChI InChI=1S/C25H22F3N7O3/c1-15-5-6-16(23(36)32-17-3-2-4-18(12-17)38-25(26,27)28)11-19(15)33-22-21-20(30-14-31-22)13-29-24(34-21)35-7-9-37-10-8-35/h2-6,11-14H,7-10H2,1H3,(H,32,36)(H,30,31,33)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117736 (US8653087, III-416) Show SMILES CN1CCC(CN2CCN(CC2)c2ncc3ncnc(Nc4cc(ccc4C)C(=O)Nc4cccc(c4)C(C)(C)C)c3n2)CC1 Show InChI InChI=1S/C35H45N9O/c1-24-9-10-26(33(45)39-28-8-6-7-27(20-28)35(2,3)4)19-29(24)40-32-31-30(37-23-38-32)21-36-34(41-31)44-17-15-43(16-18-44)22-25-11-13-42(5)14-12-25/h6-10,19-21,23,25H,11-18,22H2,1-5H3,(H,39,45)(H,37,38,40)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117739 (US8653087, III-419 | US8653087, III-562) Show SMILES COc1ccc(NC(=O)c2ccc(C)c(Nc3ncnc4cnc(nc34)N3CCN(CC4CCN(C)CC4)CC3)c2)cc1C(F)(F)F Show InChI InChI=1S/C33H38F3N9O2/c1-21-4-5-23(31(46)40-24-6-7-28(47-3)25(17-24)33(34,35)36)16-26(21)41-30-29-27(38-20-39-30)18-37-32(42-29)45-14-12-44(13-15-45)19-22-8-10-43(2)11-9-22/h4-7,16-18,20,22H,8-15,19H2,1-3H3,(H,40,46)(H,38,39,41)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117746 (US8653087, III-426) Show SMILES COCCN1CCN(CC1)c1ncc2ncnc(Nc3cc(ccc3C)C(=O)Nc3cc(ccn3)C(F)(F)F)c2n1 Show InChI InChI=1S/C27H28F3N9O2/c1-17-3-4-18(25(40)36-22-14-19(5-6-31-22)27(28,29)30)13-20(17)35-24-23-21(33-16-34-24)15-32-26(37-23)39-9-7-38(8-10-39)11-12-41-2/h3-6,13-16H,7-12H2,1-2H3,(H,31,36,40)(H,33,34,35)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117428 (US8653087, III-108) Show SMILES Cc1ccc(cc1Nc1ncnc2cnc(nc12)N1CCOCC1)C(=O)Nc1cc(CN2CCCC2)cc(c1)C(F)(F)F Show InChI InChI=1S/C30H31F3N8O2/c1-19-4-5-21(28(42)37-23-13-20(17-40-6-2-3-7-40)12-22(15-23)30(31,32)33)14-24(19)38-27-26-25(35-18-36-27)16-34-29(39-26)41-8-10-43-11-9-41/h4-5,12-16,18H,2-3,6-11,17H2,1H3,(H,37,42)(H,35,36,38)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117430 (US8653087, III-110) Show SMILES COCCNc1ncc2ncnc(Nc3cc(ccc3C)C(=O)Nc3cc(CN4CCCC4)cc(c3)C(F)(F)F)c2n1 Show InChI InChI=1S/C29H31F3N8O2/c1-18-5-6-20(13-23(18)38-26-25-24(35-17-36-26)15-34-28(39-25)33-7-10-42-2)27(41)37-22-12-19(16-40-8-3-4-9-40)11-21(14-22)29(30,31)32/h5-6,11-15,17H,3-4,7-10,16H2,1-2H3,(H,37,41)(H,33,34,39)(H,35,36,38)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117431 (US8653087, III-111) Show SMILES Cc1ccc(cc1Nc1ncnc2cnc(NC3CC3)nc12)C(=O)Nc1cc(CN2CCCC2)cc(c1)C(F)(F)F Show InChI InChI=1S/C29H29F3N8O/c1-17-4-5-19(12-23(17)38-26-25-24(34-16-35-26)14-33-28(39-25)37-21-6-7-21)27(41)36-22-11-18(15-40-8-2-3-9-40)10-20(13-22)29(30,31)32/h4-5,10-14,16,21H,2-3,6-9,15H2,1H3,(H,36,41)(H,33,37,39)(H,34,35,38)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117436 (US8653087, III-116) Show SMILES CNc1ncc2ncnc(Nc3cc(ccc3C)C(=O)Nc3cc(CN4CCCC4)cc(c3)C(F)(F)F)c2n1 Show InChI InChI=1S/C27H27F3N8O/c1-16-5-6-18(11-21(16)36-24-23-22(33-15-34-24)13-32-26(31-2)37-23)25(39)35-20-10-17(14-38-7-3-4-8-38)9-19(12-20)27(28,29)30/h5-6,9-13,15H,3-4,7-8,14H2,1-2H3,(H,35,39)(H,31,32,37)(H,33,34,36)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117443 (US8653087, III-123) Show SMILES CN(C)CCN(C)c1ccc(NC(=O)c2ccc(C)c(Nc3ncnc4cnc(NCCF)nc34)c2)cc1C(F)(F)F Show InChI InChI=1S/C28H31F4N9O/c1-17-5-6-18(13-21(17)38-25-24-22(35-16-36-25)15-34-27(39-24)33-10-9-29)26(42)37-19-7-8-23(20(14-19)28(30,31)32)41(4)12-11-40(2)3/h5-8,13-16H,9-12H2,1-4H3,(H,37,42)(H,33,34,39)(H,35,36,38)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117446 (US8653087, III-126) Show SMILES CN(C)CCN(C)c1ccc(NC(=O)c2ccc(C)c(Nc3ncnc4cnc(NCC5CCOC5)nc34)c2)cc1C(F)(F)F Show InChI InChI=1S/C31H36F3N9O2/c1-19-5-6-21(29(44)39-22-7-8-26(23(14-22)31(32,33)34)43(4)11-10-42(2)3)13-24(19)40-28-27-25(37-18-38-28)16-36-30(41-27)35-15-20-9-12-45-17-20/h5-8,13-14,16,18,20H,9-12,15,17H2,1-4H3,(H,39,44)(H,35,36,41)(H,37,38,40)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117452 (US8653087, III-132) Show SMILES COCCNc1ncc2ncnc(Nc3cc(ccc3C)C(=O)Nc3ccc(N(C)CCN(C)C)c(c3)C(F)(F)F)c2n1 Show InChI InChI=1S/C29H34F3N9O2/c1-18-6-7-19(14-22(18)38-26-25-23(35-17-36-26)16-34-28(39-25)33-10-13-43-5)27(42)37-20-8-9-24(21(15-20)29(30,31)32)41(4)12-11-40(2)3/h6-9,14-17H,10-13H2,1-5H3,(H,37,42)(H,33,34,39)(H,35,36,38)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117453 (US8653087, III-133) Show SMILES CN(C)CCN(C)c1ccc(NC(=O)c2ccc(C)c(Nc3ncnc4cnc(NC5CC5)nc34)c2)cc1C(F)(F)F Show InChI InChI=1S/C29H32F3N9O/c1-17-5-6-18(13-22(17)38-26-25-23(34-16-35-26)15-33-28(39-25)37-19-7-8-19)27(42)36-20-9-10-24(21(14-20)29(30,31)32)41(4)12-11-40(2)3/h5-6,9-10,13-16,19H,7-8,11-12H2,1-4H3,(H,36,42)(H,33,37,39)(H,34,35,38)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117458 (US8653087, III-138) Show SMILES CNc1ncc2ncnc(Nc3cc(ccc3C)C(=O)Nc3ccc(N(C)CCN(C)C)c(c3)C(F)(F)F)c2n1 Show InChI InChI=1S/C27H30F3N9O/c1-16-6-7-17(12-20(16)36-24-23-21(33-15-34-24)14-32-26(31-2)37-23)25(40)35-18-8-9-22(19(13-18)27(28,29)30)39(5)11-10-38(3)4/h6-9,12-15H,10-11H2,1-5H3,(H,35,40)(H,31,32,37)(H,33,34,36)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117467 (US8653087, III-147) Show SMILES CN(C)CCOc1cc(NC(=O)c2ccc(C)c(Nc3ncnc4cnc(NCc5ccccc5)nc34)c2)cc(c1)C(F)(F)F Show InChI InChI=1S/C32H31F3N8O2/c1-20-9-10-22(30(44)40-24-14-23(32(33,34)35)15-25(16-24)45-12-11-43(2)3)13-26(20)41-29-28-27(38-19-39-29)18-37-31(42-28)36-17-21-7-5-4-6-8-21/h4-10,13-16,18-19H,11-12,17H2,1-3H3,(H,40,44)(H,36,37,42)(H,38,39,41)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117468 (US8653087, III-148) Show SMILES CN(C)CCOc1cc(NC(=O)c2ccc(C)c(Nc3ncnc4cnc(NCc5cccnc5)nc34)c2)cc(c1)C(F)(F)F Show InChI InChI=1S/C31H30F3N9O2/c1-19-6-7-21(29(44)40-23-12-22(31(32,33)34)13-24(14-23)45-10-9-43(2)3)11-25(19)41-28-27-26(38-18-39-28)17-37-30(42-27)36-16-20-5-4-8-35-15-20/h4-8,11-15,17-18H,9-10,16H2,1-3H3,(H,40,44)(H,36,37,42)(H,38,39,41)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase B-raf [V600E] (Homo sapiens (Human))	BDBM117472 (US8653087, III-152) Show SMILES CN(C)CCOc1cc(NC(=O)c2ccc(C)c(Nc3ncnc4cnc(NC5CC5)nc34)c2)cc(c1)C(F)(F)F Show InChI InChI=1S/C28H29F3N8O2/c1-16-4-5-17(26(40)35-20-11-18(28(29,30)31)12-21(13-20)41-9-8-39(2)3)10-22(16)37-25-24-23(33-15-34-25)14-32-27(38-24)36-19-6-7-19/h4-5,10-15,19H,6-9H2,1-3H3,(H,35,40)(H,32,36,38)(H,33,34,37)	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	7.5	n/a
Boehringer Ingelheim International GmbH US Patent					Assay Description The final concentration of DMSO is 5%. 10 μL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 ...				US Patent US8653087 (2014) BindingDB Entry DOI: 10.7270/Q2CR5S1G
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 1090 total )  |  Next  |  Last  >>

Jump to: